MUCCI, MATTEO
 Distribuzione geografica
Continente #
EU - Europa 223
NA - Nord America 184
AS - Asia 90
SA - Sud America 21
OC - Oceania 6
AF - Africa 2
Totale 526
Nazione #
US - Stati Uniti d'America 159
IT - Italia 117
SG - Singapore 58
IE - Irlanda 26
CA - Canada 22
BR - Brasile 21
DE - Germania 21
CN - Cina 16
FR - Francia 11
GB - Regno Unito 8
FI - Finlandia 7
AT - Austria 6
AU - Australia 6
SE - Svezia 6
ES - Italia 5
RU - Federazione Russa 5
KR - Corea 4
BZ - Belize 3
CZ - Repubblica Ceca 3
HK - Hong Kong 3
NL - Olanda 3
PL - Polonia 3
IL - Israele 2
IR - Iran 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
EE - Estonia 1
GR - Grecia 1
IN - India 1
MA - Marocco 1
ZA - Sudafrica 1
Totale 526
Città #
Singapore 49
Pescara 31
Dublin 26
Houston 15
Santa Clara 14
Chieti 13
Montreal 13
Chandler 12
The Dalles 12
San Buono 10
Camerino 9
Nuremberg 9
Ashburn 8
New York 7
Lappeenranta 5
Los Angeles 5
Princeton 5
Toronto 5
Boardman 4
Jundiaí 4
Rochester 4
Rome 4
Spoltore 4
Alba 3
Düsseldorf 3
Frankfurt am Main 3
Hong Kong 3
Melbourne 3
Piotrkow Trybunalski 3
San Giovanni Teatino 3
Saskatoon 3
Seattle 3
Shanghai 3
Vienna 3
Altamura 2
Aprilia 2
Bernareggio 2
Curitiba 2
Falkenstein 2
Helsinki 2
Iesi 2
Lauterbourg 2
Ness Ziona 2
Olomouc 2
Prato 2
San Cristóbal de La Laguna 2
San Francisco 2
Santander 2
Silvi 2
São José 2
Washington 2
Xi'an 2
Adelaide 1
Ancona 1
Antalya 1
Ascoli Piceno 1
Athens 1
Augusta 1
Blumenau 1
Brisbane 1
Brno 1
Cape Town 1
Castignano 1
Catuji 1
Charlotte 1
Clamart 1
Coronel Fabriciano 1
Fes 1
Florianópolis 1
Giresun 1
Guangzhou 1
Heidelberg 1
Hoffman 1
Horizonte 1
Hwaseong-si 1
Jacksonville 1
Junqueirópolis 1
Kurrara 1
Lanciano 1
London 1
L’Aquila 1
Macapá 1
Milan 1
Montesilvano Marina 1
Moscow 1
Ottawa 1
Oxford 1
Paderborn 1
Paulínia 1
Ponte Nova 1
Portsmouth 1
Pune 1
Raleigh 1
Riesi 1
Romola 1
Rondonópolis 1
Roubaix 1
San Vito Chietino 1
Santa Fe 1
Selvazzano Dentro 1
Totale 385
Nome #
Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease. 122
Microvascular and Macrovascular Endothelial Cell Isolation and Purification from Lung-Derived Samples 78
Characterization of cyclooxygenase-2 acetylation and prostanoid inhibition by aspirin in cellular systems 70
null 51
null 49
Characterization of the acetylation of cyclooxygenase-isozymes and targeted lipidomics of eicosanoids in serum and colon cancer cells by the new aspirin formulation IP1867B versus aspirin in vitro 47
Specialized pro-resolving lipid mediators and resolution of viral diseases 33
Mitapivat, a pyruvate kinase activator, improves transfusion burden and reduces iron overload in β-thalassemic mice 24
Maternal, newborn and breast milk concentrations of elexacaftor/tezacaftor/ivacaftor in a F508del heterozygous woman with cystic fibrosis following successful pregnancy 23
Single cell–level pro-resolving actions of Resolvin D1 and D2 on Staphylococcus aureus lung infection and inflammation in cystic fibrosis 22
Targeting platelet activation with pro-resolving mediators: an innovative strategy to dampen lung inflammation in cystic fibrosis 17
Development and application of a liquid chromatography–mass spectrometry method for monitoring CFTR modulators in biological fluids: a step forward in personalized CF treatment 17
The specific deletion of cyclooxygenase-1 in megakaryocytes/platelets reduces intestinal polyposis in ApcMin/+ mice 12
Inflammation and Cancer: From the Development of Personalized Indicators to Novel Therapeutic Strategies 8
Immunoregulatory mechanisms of the arachidonic acid pathway in cancer 7
Inflammation and epithelial–mesenchymal transition in a CFTR‐depleted human bronchial epithelial cell line revealed by proteomics and human organ‐on‐a‐chip 5
Totale 585
Categoria #
all - tutte 3.627
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.627


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 1 1 1 1 2 0 1 1
2021/20227 0 0 1 0 0 0 0 0 3 0 1 2
2022/202396 5 7 2 3 4 10 5 24 15 2 6 13
2023/2024152 7 4 8 3 13 17 11 30 9 24 14 12
2024/2025322 22 55 37 11 36 15 43 41 14 32 16 0
Totale 585